CVPath Institute, Inc. (CVPath) is a non-profit organization. It is principally engaged in providing consultative and research services. The company offers its services to create awareness about cardiac and vascular diseases. CVPath offers histopathology and diagnostic services for the evaluation and improvement of efficacy of stents and various other interventional cardiovascular devices. Further, it offers advanced training programs for clinicians related to cardiovascular disease. It also focuses on the characterization, imaging, and treatment of fatal disease, atherosclerotic plaques. Furthermore, it focuses on the the development of cell-based therapies for reducing the burden of ischemia in heart failure. The company partners with other investigators for designing, improvement, and evaluation of interventional devices before clinical studies. CVPath is headquartered at Gaithersburg in Maryland, the US.